CA2425827A1 - Acides nucleiques et polypeptides - Google Patents

Acides nucleiques et polypeptides Download PDF

Info

Publication number
CA2425827A1
CA2425827A1 CA002425827A CA2425827A CA2425827A1 CA 2425827 A1 CA2425827 A1 CA 2425827A1 CA 002425827 A CA002425827 A CA 002425827A CA 2425827 A CA2425827 A CA 2425827A CA 2425827 A1 CA2425827 A1 CA 2425827A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
protein
cells
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002425827A
Other languages
English (en)
Inventor
Y. Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A. Zhao
Feiyan Ren
Aidong J. Xue
Yonghong Yang
Tom Wehrman
Radoje T. Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2425827A1 publication Critical patent/CA2425827A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des acides nucléiques, des séquences de polypeptides codées par ces acides nucléiques, et leur utilisation.
CA002425827A 2000-10-12 2001-10-11 Acides nucleiques et polypeptides Abandoned CA2425827A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68752700A 2000-10-12 2000-10-12
US09/687,527 2000-10-12
PCT/US2001/027760 WO2002031111A2 (fr) 2000-10-12 2001-10-11 Acides nucleiques et polypeptides

Publications (1)

Publication Number Publication Date
CA2425827A1 true CA2425827A1 (fr) 2002-04-18

Family

ID=24760764

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002425827A Abandoned CA2425827A1 (fr) 2000-10-12 2001-10-11 Acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1325120A4 (fr)
AU (1) AU2001296235A1 (fr)
CA (1) CA2425827A1 (fr)
WO (1) WO2002031111A2 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A3 (fr) * 1999-07-29 2004-04-21 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
EP1228085A4 (fr) * 1999-11-05 2005-02-02 Gen Hospital Corp Molecules d'acides nucleiques et polypeptides gridlock, et methodes diagnostiques et therapeutiques associees
US8642284B1 (en) 1999-12-15 2014-02-04 Massachusetts Institute Of Technology Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
US7452664B2 (en) 1999-12-15 2008-11-18 Massachusetts Institute Of Technology Methods for identifying agents which alter histone protein acetylation
DK1967586T3 (da) 2000-01-26 2011-06-20 Agensys Inc 84P2A9: prostata- og testikelspecifikt protein med høj ekspression ved prostatacancer
US6774223B2 (en) 2000-06-28 2004-08-10 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
JP2002034565A (ja) * 2000-07-19 2002-02-05 Japan Science & Technology Corp 細菌ｄｎａを特異的に認識する受容体タンパク質
US6515109B1 (en) * 2000-10-12 2003-02-04 Exelixis, Inc. Human ECT2 polypeptide
US20060127890A1 (en) * 2000-10-30 2006-06-15 Nobuyuki Koyama Novel gene overexpressed in heart and skeletal muscle and use thereof
US7572575B2 (en) 2000-12-13 2009-08-11 Massachusetts Institute Of Technology SIR2 activity
MXPA03005436A (es) 2000-12-20 2004-05-05 Bristol Myers Squibb Co Polinucleotidos novedosos que codifican fosfastasas humanas.
EP1383797A2 (fr) * 2001-02-07 2004-01-28 Universiteit Maastricht Marqueurs de plaques d'atherosclerose instables
ES2315391T3 (es) * 2001-04-10 2009-04-01 Agensys, Inc. Acido nucleico y su correspondiente proteina llamada 121pza3 util en el tratamiento y la deteccion del cancer.
JP2004528046A (ja) * 2001-06-05 2004-09-16 エクセリクシス・インコーポレイテッド ｐ５３経路のモディファイヤーとしてのＤＧＫｓおよび使用方法
WO2003004989A2 (fr) 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, trousses, et procedes d'identification, d'evaluation, de prevention, et de therapie pour le cancer du sein
JP2003024080A (ja) * 2001-07-19 2003-01-28 Univ Tokyo ｐ５３依存性アポトーシス誘導タンパク質、およびアポトーシス調節剤のスクリーニング方法
AU2003281314A1 (en) * 2002-07-09 2004-01-23 Takeda Pharmaceutical Company Limited Nove protein and use thereof
JP4301541B2 (ja) * 2002-09-05 2009-07-22 独立行政法人科学技術振興機構 Ｓｍｇ−１結合タンパク質及びその活性を制御する物質のスクリーニング方法
JP2006521082A (ja) * 2002-09-11 2006-09-21 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための新規組成物と方法
WO2004042386A2 (fr) * 2002-11-08 2004-05-21 Bayer Healthcare Ag Moyens diagnostiques et therapeutiques destines a des maladies associees a la phosphodiesterase 11a3 (pde11a3) humaine
AU2003901055A0 (en) * 2003-02-17 2003-03-20 Nathan E Hall Methods for inhibiting signal transduction
WO2005033266A2 (fr) * 2003-05-07 2005-04-14 University Of Massachusetts Regulation de l'expression d'acheron
US20050026194A1 (en) * 2003-06-20 2005-02-03 Tularik Inc. Gene amplification and overexpression in cancer
WO2005014817A2 (fr) * 2003-08-07 2005-02-17 Compugen Ltd. Homologues de type chordine
CN1898260A (zh) * 2003-10-28 2007-01-17 普罗特米克斯发现有限公司 具有抗肥胖活性的肽及其它相关应用
US7638490B2 (en) 2004-02-09 2009-12-29 Eisai R&D Managment Co., Ltd. Methods of affecting feeding and weight in mammals by administration of relaxin-3
US20080199468A1 (en) * 2004-02-24 2008-08-21 Oncotherapy Science, Inc. Method For Diagnosing Colorectal Cancers
WO2005118811A1 (fr) * 2004-06-02 2005-12-15 Tss Biotech Inc. Nouveau polypeptide utile pour diagnostiquer et pour traiter le cancer
MX2007002043A (es) 2004-08-16 2007-10-11 Quark Biotech Inc Usos terapeuticos de los inhibidores del rtp801.
US7531634B2 (en) * 2004-12-03 2009-05-12 University Of Pittsburgh Bladder matrix protein peptides and methods of detection of bladder cancer
CN101175862A (zh) * 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
US20070099830A1 (en) 2005-04-21 2007-05-03 Massachusetts Institute Of Technology Sirt4 activities
WO2006115295A1 (fr) * 2005-04-25 2006-11-02 University Of Yamanashi Compositions et methodes de traitement de troubles hemostatiques associes a la transduction du signal du clec-2
UY30097A1 (es) 2006-01-20 2007-08-31 Atugen Ag Usos terapeuticos de inhibidores de rtp801
GB2450840B (en) 2006-05-11 2010-12-29 Quark Pharmaceuticals Inc Screening Systems Utilizing RTP801
WO2007141796A2 (fr) 2006-06-09 2007-12-13 Quark Pharmaceuticals, Inc. Utilisations thérapeutiques d'inhibiteurs de rtp801l
EP2476697B1 (fr) 2006-10-17 2015-06-17 Oncotherapy Science, Inc. Vaccins de peptide pour cancers exprimant les polypeptides MPHOSPH1
JP2010518880A (ja) 2007-02-26 2010-06-03 クアーク・ファーマスーティカルス、インコーポレイテッド Ｒｔｐ８０１のインヒビター及びその疾患の治療における使用
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
CN102165061A (zh) * 2008-07-28 2011-08-24 艾德拉药物股份有限公司 通过反义寡核苷酸来调制toll样受体9表达
US8975086B2 (en) 2008-08-28 2015-03-10 Oncotherapy Science, Inc. Method for treating or preventing bladder cancer using the DEPDC1 polypeptide
ES2617434T3 (es) 2009-03-18 2017-06-19 Oncotherapy Science, Inc. Péptidos NEIL3 y vacunas que incluyen los mismos
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
GB201009654D0 (en) * 2010-06-09 2010-07-21 Cancer Res Technology Nucleic acid methyltransferase
TWI467016B (zh) * 2011-08-31 2015-01-01 Taipei Veteran General Hospital Ｏｃｔ４及ＳｉｒＴ１之基因傳遞及其醫藥組合物
US10653782B2 (en) * 2014-11-25 2020-05-19 Nortwestern University Retroviral particles expressing Sirt1 embedded within PPCN
EP3336186A4 (fr) 2015-08-12 2019-03-06 OncoTherapy Science, Inc. Peptide dérivé du depdc1 et vaccin le contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (fr) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 proteines humaines secretees
JP2003530838A (ja) * 2000-04-12 2003-10-21 ヒューマン ゲノム サイエンシズ インコーポレイテッド アルブミン融合タンパク質

Also Published As

Publication number Publication date
WO2002031111A3 (fr) 2002-10-17
EP1325120A2 (fr) 2003-07-09
EP1325120A4 (fr) 2005-05-25
AU2001296235A1 (en) 2002-04-22
WO2002031111A2 (fr) 2002-04-18

Similar Documents

Publication Publication Date Title
CA2425827A1 (fr) Acides nucleiques et polypeptides
US20070042392A1 (en) Novel nucleic acids and polypeptides
CA2421949A1 (fr) Noveaux acides nucleiques et polypeptides
WO2001053455A2 (fr) Nouveaux acides nucleiques et polypeptides associes
EP1261743A2 (fr) Nouveaux acides nucleiques et polypeptides
WO2001075067A2 (fr) Nouveaux acides nucleiques et polypeptides
CA2429343A1 (fr) Nouveaux acides nucleiques et polypeptides
EP1578989A2 (fr) Nouveaux acides nucleiques et polypeptides secretes
EP1430112A2 (fr) Nouveaux acides nucleiques et polypeptides
CA2440747A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1276751A2 (fr) Nouveaux acides nucleiques et polypeptides
AU2734401A (en) Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides
CA2421122A1 (fr) Nouveaux acides nucleiques et polypeptides
US20070060743A1 (en) Novel nucleic acids and polypeptides
CA2430584A1 (fr) Nouveaux acides nucleiques et polypeptides
US20040053250A1 (en) Novel arginine-rich protein-like nucleic acids and polypeptides
WO2001053485A1 (fr) Procedes et substances relatifs a de nouveaux polypeptides du type von willebrand/thrombospondine et a des polynucleotides
AU2001255214B2 (en) Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
WO2002077180A2 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
CA2409164A1 (fr) Nouveaux acides nucleiques et polypeptides
US20050170374A1 (en) Novel nucleic acids and polypeptides
EP1268762A1 (fr) Nouveaux acides nucleiques et polypeptides
CA2406121A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1591448A2 (fr) Nouveaux acides nucléiques et polypeptides
CA2453344A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides

Legal Events

Date Code Title Description
FZDE Discontinued